CONDUIT PHARMACEUTICALS INC. - COMMON STOCK
0,0820
08-января-25 16:45:00
15 мин. задержка
Акции
-0,0120
-12,77%
Сегодняшний диапазон
0,0820 - 0,1318
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
12 дек 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
21 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
19 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
04 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
01 ноя 2024 16:45:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
28 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
12 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
08 авг 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
16 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Join Russell 3000® Index
13 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
19 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
11 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
31 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
02 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
11 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >